Definium’s LSD formula produces ‘best data ever seen’ in a pivotal depression trial, CEO says
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Definium’s LSD formula produces ‘best data ever seen’ in a pivotal depression trial, CEO says" is generating significant coverage in the Business category, with 7 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include BioSpace, Yahoo Finance, Psychedelic Alpha and WSJ. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 95d ago.
Quick answers
Why is "Definium’s LSD formula produces ‘best data ever seen’ in a pivotal depression tr" trending?
Because 7 independent news sources published 7 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Definium’s LSD-based therapy elicits ‘profound’ efficacy in Phase 3 depression trial BioSpace · 97d ago
- Definium Therapeutics (DFTX) Hits New High on Impressive Drug Candidate Trial Yahoo Finance · 97d ago
- Breaking: Definium Lands Positive Phase 3, LSD Candidate Shows Strong Antidepressant Effect Psychedelic Alpha · 97d ago
- 🔎 Under the Radar: Definium Shares Propelled by Strong Psychedelic Results WSJ · 97d ago
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder Business Wire · 97d ago
- Definium's LSD-based drug scores win in key major depressive disorder study FirstWord Pharma · 97d ago
- Definium LSD therapy helped patients with major depression in late-stage trial statnews.com · 97d ago
Topics
Related trends
Pacific Palisades CEO convicted of millions in fraud in smart ring case
Esos Rings CEO Michelle Bisnoff is convicted in a million-dollar smart ring fraud scheme.
Cavco CEO unveils manufactured home without steel chassis at National Mall showcase
HUD hosts the Innovative Housing Showcase on the National Mall, highlighting manufactured housing engineering and industry ingenuity.
Microsoft CEO Discusses His Goals For The Future Of Xbox, Feels 'Fantastic' About The IP Portfolio
Microsoft’s Xbox chief vows future growth amid layoffs and a delayed Halo sequel, sparking industry debate.
Microsoft CEO Attempts To Kill Remaining Xbox Goodwill
Microsoft’s chief is under fire for moves seen as eroding Xbox’s hard‑won brand goodwill, sparking debate across the gaming community.
Inside Kalshi CEO Tarek Mansour's testy relationship with Indian casinos -- and how it could pose an existential threat: 'Lying little twerp'
Kalshi faces an existential threat as a US appeals court rules that states can regulate its prediction markets.
Microsoft CEO On Recent Xbox Layoffs: 'There's Some Amount Of Streamlining Asha Is Doing...Which Is Great To See'
Microsoft CEO Satya Nadella publicly praises recent Xbox layoffs as streamlining that brings the company closer to a headcount goal.